RESUMEN
BACKGROUND/AIMS: The present study aimed to evaluate the safety and efficacy of simeprevir-based triple therapy with reduced doses of pegylated interferon (PEG-IFN) and ribavirin for interferon (IFN) ineligible patients, such as elderly and/or cirrhotic patients, and to elucidate the factors contributing to a sustained virologic response (SVR). METHODS: One hundred IFN ineligible patients infected with genotype 1b hepatitis C virus (HCV) were treated. Simeprevir (100 mg) was given orally together with reduced doses of PEG-IFN-α 2a (90 µg), and ribavirin (200 mg less than the recommended dose). RESULTS: The patients' median age was 70 years, and 70 patients were cirrhotic. Three patients (3%) discontinued treatment due to adverse events. The SVR rate was 64%. Factors that significantly contributed to the SVR included the γ-glutamyl transferase and α-fetoprotein levels, interleukin- 28B (IL28B) polymorphism status, and the level and reduction of HCV RNA at weeks 2 and 4. The multivariate analysis showed that the IL28B polymorphism status was the only independent factor that predicted the SVR, with a positive predictive value of 77%. CONCLUSIONS: Simeprevir-based triple therapy with reduced doses of PEG-IFN and ribavirin was safe and effective for IFN ineligible patients infected with genotype 1b HCV. IL28B polymorphism status was a useful predictor of the SVR.
Asunto(s)
Antivirales/administración & dosificación , Hepacivirus/efectos de los fármacos , Hepatitis C/tratamiento farmacológico , Interferón-alfa/administración & dosificación , Polietilenglicoles/administración & dosificación , Ribavirina/administración & dosificación , Simeprevir/administración & dosificación , Anciano , Quimioterapia Combinada , Femenino , Genotipo , Hepacivirus/genética , Hepatitis C/genética , Hepatitis C/virología , Humanos , Masculino , Estudios Prospectivos , Proteínas Recombinantes/administración & dosificación , Respuesta Virológica SostenidaRESUMEN
We present a rare case of adenocarcinoma arising from a heterotopic pancreas in the duodenum, and review the associated literature. A 62-year-old woman was admitted to our hospital, complaining of vomiting and epigastralgia. Imaging studies revealed advanced gastric cancer with a gastric outlet obstruction. Whipple's operation and resection of the regional lymph node were performed because of a direct invasion to the pancreas. Histopathologic examination of the resected specimen demonstrated the malignant transformation of a hetrotopic pancreas in the duodenum. At the 12-month follow-up, there was no recurrence of symptoms. The prognosis of adenocarcinoma arising from a heterotopic pancreas is not known. Further accumulation of cases and investigation of this entity are necessary.
Asunto(s)
Adenocarcinoma/secundario , Coristoma/complicaciones , Enfermedades Duodenales/complicaciones , Neoplasias Duodenales/secundario , Páncreas , Neoplasias Pancreáticas/patología , Neoplasias Gástricas/secundario , Adenocarcinoma/diagnóstico , Adenocarcinoma/etiología , Coristoma/diagnóstico , Enfermedades Duodenales/diagnóstico , Neoplasias Duodenales/diagnóstico , Neoplasias Duodenales/etiología , Femenino , Obstrucción de la Salida Gástrica/etiología , Humanos , Persona de Mediana Edad , Neoplasias Pancreáticas/etiología , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/etiologíaRESUMEN
We report the case of a 59-year-old female who developed facial edema together with hypoproteinemia. On the basis of (99m)Tc-human serum albumin scintigraphy and a1-antitrypsin clearance, she was diagnosed with protein-losing gastroenteropathy. Furthermore, she was diagnosed with Sjögren syndrome on the basis of eye and oral dryness, positive result with anti-SSA antibody, and salivary gland biopsy. Her symptoms improved with the use of immunosuppressive agents following steroid pulse therapy. Therefore, steroid pulse therapy and immunosuppressive agents should be considered as possible effective treatment strategies for protein-losing gastroenteropathy associated with autoimmune diseases.
RESUMEN
We report here the case of an 83-year-old man who was treated for unconsciousness and hypoglycemia (39 mg/dL) accompanied by marked elevation of serum immunoreactive insulin (IRI) (4,760 µIU/mL). We diagnosed his condition as insulin autoimmune syndrome (IAS, Hirata disease) because of a high insulin autoantibody (IAA) titer (>90%: bound/total) and no history of exogenous insulin administration. Reactive hypoglycemia occurred due to immediate association followed by dissociation between insulin and insulin autoantibodies after glucose or food intake. An α-glucosidase inhibitor in combination with frequent small meals reduced the postprandial hyperglycemia (glucose spike) and ameliorated the reactive hypoglycemia.
Asunto(s)
Autoanticuerpos/sangre , Enfermedades Autoinmunes/complicaciones , Hipoglucemia/etiología , Hipoglucemia/inmunología , Anticuerpos Insulínicos/sangre , Insulina/sangre , Insulina/inmunología , Anciano , Anciano de 80 o más Años , Reacciones Antígeno-Anticuerpo/inmunología , Enfermedades Autoinmunes/sangre , Enfermedades Autoinmunes/inmunología , Glucemia , Glucosa/administración & dosificación , Humanos , Hipoglucemia/sangre , Cinética , Masculino , Periodo Posprandial , Síndrome , Inconsciencia/sangre , Inconsciencia/etiología , Inconsciencia/inmunologíaRESUMEN
Congenital portal systemic encephalopathy without liver cirrhosis and/or portal hypertension is rare. An 86-year-old man with senile dementia was admitted due to disturbance of consciousness. His serum ammonia level was high, but there was no evidence of liver cirrhosis or portal hypertension on laboratory tests and upper abdominal enhanced computed tomography (CT). However, on lower abdominal enhanced CT, a meso-caval shunt was found in the right lower abdomen. Superior mesenteric arteriography revealed a shunt flowing into the inferior vena cava via the right gonadal vein. The shunt was closed by balloon occluded retrograde transvenous obliteration, and dementia-like symptoms improved.
Asunto(s)
Enfermedad de Alzheimer/diagnóstico , Errores Diagnósticos , Encefalopatía Hepática/diagnóstico , Anciano de 80 o más Años , Enfermedad de Alzheimer/sangre , Amoníaco/sangre , Angiografía , Encefalopatía Hepática/sangre , Humanos , Masculino , Mesenterio/irrigación sanguínea , Radiografía AbdominalRESUMEN
This report describes a 37-year-old man with tumor-induced osteomalacia (TIO). The patient had hypophosphatemia and elevated fibroblast growth factor 23 (FGF23) in the peripheral blood. Magnetic resonance imaging detected an abnormal mass in the left greater trochanter. Venous sampling revealed a significantly higher level of FGF23 in the left common iliac vein (proximal to the tumor), verifying that the tumor is responsible for TIO. The serum level of FGF23 decreased and symptoms improved after removal of the tumor. The combined diagnostic procedures of MRI and venous sampling for FGF23 effectively detected the tumor responsible for TIO.